Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] was reported 24027 times

Drugs of the Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 94 0.7287
1 PAROXYSMAL EXTREME PAIN DISORDER 17 0.6800
2 CLOACAL EXSTROPHY 32 0.5424
3 ULTRASOUND ANTENATAL SCREEN 51 0.5312
4 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 147 0.5288
5 CONJUNCTIVALISATION 16 0.5000
6 BLADDER AGENESIS 37 0.5000
7 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 48 0.4324
8 PACHYGYRIA 15 0.4167
9 SPINOCEREBELLAR DISORDER 18 0.3830
10 AIDS ENCEPHALOPATHY 22 0.3793
11 VIRAL MUTATION IDENTIFIED 1313 0.3561
12 PINEALOBLASTOMA 33 0.3548
13 IMMUNE RECONSTITUTION SYNDROME 453 0.3509
14 HIV VIRAEMIA 72 0.3429
15 HYPERANDROGENISM 30 0.3191
16 VIROLOGIC FAILURE 1709 0.3175
17 GASTROINTESTINAL DISORDER CONGENITAL 32 0.3019
18 TUBERCULOID LEPROSY 19 0.2923
19 GENETIC POLYMORPHISM 16 0.2807
20 AIDS RELATED COMPLICATION 17 0.2615
21 MITOCHONDRIAL TOXICITY 206 0.2509
22 CARDIAC MALPOSITION 19 0.2500
23 LIPODYSTROPHY ACQUIRED 512 0.2409
24 POSTPARTUM SEPSIS 13 0.2281
25 DANDY-WALKER SYNDROME 59 0.2278
26 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 72 0.2149
27 GENITALIA EXTERNAL AMBIGUOUS 36 0.2081
28 CASTLEMAN'S DISEASE 12 0.2069
29 CAUDAL REGRESSION SYNDROME 31 0.1987
30 SUPERNUMERARY NIPPLE 16 0.1951
31 MECONIUM STAIN 30 0.1948
32 ENLARGED CLITORIS 32 0.1939
33 ASTROCYTOMA MALIGNANT 19 0.1845
34 BIRTH MARK 38 0.1827
35 HIV INFECTION 524 0.1737
36 ISOSPORIASIS 13 0.1667
37 FOETAL EXPOSURE DURING DELIVERY 113 0.1667
38 CONGENITAL GENITAL MALFORMATION 26 0.1625
39 CONGENITAL UMBILICAL HERNIA 54 0.1448
40 SECONDARY SYPHILIS 14 0.1414
41 CD4 LYMPHOCYTES ABNORMAL 29 0.1381
42 TETHERED CORD SYNDROME 30 0.1357
43 CONGENITAL NAEVUS 19 0.1338
44 BRACHYDACTYLY 26 0.1320
45 BLOOD HIV RNA INCREASED 228 0.1256
46 VERTICAL INFECTION TRANSMISSION 14 0.1239
47 TRISOMY 18 47 0.1234
48 CSF HIV ESCAPE SYNDROME 17 0.1232
49 ACOUSTIC STIMULATION TESTS ABNORMAL 19 0.1218
50 MENINGOMYELOCELE 72 0.1200
51 PATHOGEN RESISTANCE 1063 0.1165
52 CONFUSIONAL AROUSAL 18 0.1118
53 CD4 LYMPHOCYTES INCREASED 26 0.1116
54 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 20 0.1099
55 GASTROINTESTINAL MALFORMATION 22 0.1053
56 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 519 0.1040
57 CD4 LYMPHOCYTES DECREASED 219 0.1022
58 DEXTROCARDIA 19 0.1011
59 THYMUS ENLARGEMENT 16 0.1000
60 EXOMPHALOS 52 0.0968
61 HYDROPS FOETALIS 59 0.0962
62 GENOTYPE DRUG RESISTANCE TEST POSITIVE 97 0.0944
63 MITOCHONDRIAL MYOPATHY 20 0.0917
64 KAPOSI'S SARCOMA 46 0.0916
65 VIRAL LOAD ABNORMAL 16 0.0914
66 MACROCEPHALY 35 0.0902
67 POST PROCEDURAL HYPOTHYROIDISM 18 0.0849
68 HIV TEST POSITIVE 53 0.0802
69 CHORIOAMNIONITIS 15 0.0789
70 NODULAR REGENERATIVE HYPERPLASIA 50 0.0779
71 LIPOATROPHY 70 0.0735
72 POLYDACTYLY 85 0.0733
73 LOW SET EARS 30 0.0730
74 LARYNGOMALACIA 23 0.0687
75 DEFORMITY THORAX 13 0.0674
76 DRUG RESISTANCE 1729 0.0672
77 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 71 0.0656
78 ENCEPHALOCELE 16 0.0643
79 MUSCULOSKELETAL DEFORMITY 15 0.0641
80 MATERNAL CONDITION AFFECTING FOETUS 14 0.0633
81 CONGENITAL HYDROCEPHALUS 32 0.0631
82 UMBILICAL CORD ABNORMALITY 33 0.0626
83 NEURODEVELOPMENTAL DISORDER 42 0.0621
84 MENINGITIS TUBERCULOUS 34 0.0608
85 ANAL ATRESIA 32 0.0599
86 ACQUIRED IMMUNODEFICIENCY SYNDROME 31 0.0597
87 MALARIA 42 0.0596
88 MENINGITIS CRYPTOCOCCAL 103 0.0589
89 SPINE MALFORMATION 20 0.0576
90 NEURAL TUBE DEFECT 41 0.0564
91 FAT REDISTRIBUTION 13 0.0560
92 PORTAL HYPERTENSIVE GASTROPATHY 31 0.0550
93 STILLBIRTH 261 0.0540
94 FANCONI SYNDROME ACQUIRED 92 0.0524
95 CHRONIC RESPIRATORY DISEASE 18 0.0510
96 ACUTE HIV INFECTION 12 0.0486
97 RENAL TUBULAR DYSFUNCTION 27 0.0478
98 VANISHING BILE DUCT SYNDROME 53 0.0475
99 EXTRAPULMONARY TUBERCULOSIS 14 0.0475
100 CLEFT LIP AND PALATE 52 0.0465
101 DEATH NEONATAL 64 0.0460
102 RETINAL TOXICITY 47 0.0456
103 MULTIPLE-DRUG RESISTANCE 141 0.0454
104 CYTOMEGALOVIRUS CHORIORETINITIS 88 0.0451
105 ATRIOVENTRICULAR SEPTAL DEFECT 21 0.0447
106 VIRAL LOAD INCREASED 169 0.0435
107 ACQUIRED GENE MUTATION 57 0.0435
108 BONE DEMINERALISATION 46 0.0434
109 MITOCHONDRIAL CYTOPATHY 19 0.0432
110 FANCONI SYNDROME 61 0.0431
111 FIBROUS HISTIOCYTOMA 15 0.0427
112 PORTAL HYPERTENSION 128 0.0415
113 TRISOMY 21 52 0.0413
114 CONGENITAL MUSCULOSKELETAL ANOMALY 18 0.0408
115 ANENCEPHALY 23 0.0407
116 DEGENERATIVE BONE DISEASE 18 0.0406
117 CONDUCTIVE DEAFNESS 13 0.0405
118 EXPOSURE DURING BREAST FEEDING 133 0.0401
119 SYPHILIS 29 0.0399
120 SEPSIS NEONATAL 32 0.0394
121 RENAL DYSPLASIA 15 0.0388
122 NON-ALCOHOLIC FATTY LIVER 13 0.0386
123 CHRONIC HEPATITIS C 15 0.0380
124 LYMPH NODE TUBERCULOSIS 28 0.0376
125 CEREBELLAR ATAXIA 36 0.0376
126 LIPOHYPERTROPHY 23 0.0370
127 PORPHYRIA NON-ACUTE 16 0.0368
128 ADRENAL SUPPRESSION 31 0.0368
129 URINARY TRACT INFLAMMATION 13 0.0361
130 CUSHING'S SYNDROME 25 0.0360
131 ANAEMIA NEONATAL 17 0.0353
132 PSYCHIATRIC DECOMPENSATION 68 0.0348
133 GENE MUTATION 68 0.0343
134 HYPERLACTACIDAEMIA 91 0.0339
135 LEFT VENTRICULAR DILATATION 17 0.0333
136 VIRAEMIA 46 0.0332
137 EXTRAOCULAR MUSCLE PARESIS 15 0.0327
138 OPHTHALMOPLEGIA 51 0.0323
139 SPINA BIFIDA 66 0.0317
140 SKULL MALFORMATION 20 0.0311
141 GLYCOSURIA 42 0.0311
142 DYSLIPIDAEMIA 157 0.0309
143 PULMONARY TUBERCULOSIS 131 0.0306
144 CEREBRAL TOXOPLASMOSIS 28 0.0300
145 INTRA-UTERINE DEATH 47 0.0293
146 SPEECH DISORDER DEVELOPMENTAL 84 0.0293
147 CRYPTOCOCCOSIS 46 0.0282
148 NECROTISING RETINITIS 18 0.0281
149 MOLLUSCUM CONTAGIOSUM 15 0.0278
150 BLEEDING VARICOSE VEIN 15 0.0277
151 ANAL CANCER 26 0.0268
152 VISCERAL LEISHMANIASIS 19 0.0263
153 PREMATURE RUPTURE OF MEMBRANES 62 0.0257
154 VOLVULUS 59 0.0249
155 MYCOBACTERIUM AVIUM COMPLEX INFECTION 66 0.0246
156 PULMONARY HYPOPLASIA 19 0.0241
157 FAT TISSUE INCREASED 34 0.0234
158 HEPATIC FIBROSIS 80 0.0233
159 HEPATOSPLENOMEGALY 59 0.0230
160 PNEUMOCYSTIS JIROVECI PNEUMONIA 51 0.0229
161 PLACENTAL INSUFFICIENCY 18 0.0224
162 FOETAL EXPOSURE DURING PREGNANCY 1802 0.0221
163 AMNIOTIC CAVITY INFECTION 16 0.0221
164 RENAL TUBULAR DISORDER 62 0.0220
165 OSTEOMALACIA 34 0.0220
166 NEUROPSYCHIATRIC SYMPTOMS 19 0.0210
167 LIPIDS ABNORMAL 15 0.0207
168 CYSTITIS NONINFECTIVE 27 0.0201
169 PORTAL VEIN THROMBOSIS 65 0.0201
170 VENTRICULAR SEPTAL DEFECT 115 0.0201
171 GRANULOMATOUS LIVER DISEASE 14 0.0199
172 BLOOD AMYLASE INCREASED 34 0.0198
173 HYDROCELE 21 0.0197
174 FOETAL DISTRESS SYNDROME 41 0.0193
175 CSF PROTEIN INCREASED 16 0.0193
176 HISTOPLASMOSIS 34 0.0192
177 EYELID PTOSIS 193 0.0190
178 SJS-TEN OVERLAP 13 0.0185
179 OESOPHAGEAL VARICES HAEMORRHAGE 40 0.0184
180 DISSEMINATED TUBERCULOSIS 47 0.0183
181 HEPATITIS B 110 0.0182
182 CEREBRAL VENTRICLE DILATATION 21 0.0182
183 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 20 0.0182
184 VARICES OESOPHAGEAL 55 0.0182
185 LOW BIRTH WEIGHT BABY 143 0.0180
186 SMALL FOR DATES BABY 89 0.0179
187 TWIN PREGNANCY 15 0.0178
188 LIMB MALFORMATION 14 0.0177
189 CAESAREAN SECTION 206 0.0177
190 MATERNAL DRUGS AFFECTING FOETUS 133 0.0173
191 PLACENTAL DISORDER 16 0.0169
192 MYCOBACTERIAL INFECTION 29 0.0168
193 TOXOPLASMOSIS 18 0.0167
194 SUPERINFECTION BACTERIAL 13 0.0164
195 ABORTION INDUCED 153 0.0162
196 LYMPHADENITIS 39 0.0161
197 CHRONIC HEPATITIS 13 0.0160
198 ABDOMINAL SEPSIS 14 0.0159
199 OPPORTUNISTIC INFECTION 29 0.0157
200 DEVELOPMENTAL HIP DYSPLASIA 13 0.0156
201 BLOOD LACTIC ACID INCREASED 82 0.0156
202 OESOPHAGEAL CANDIDIASIS 61 0.0153
203 NON-HODGKIN'S LYMPHOMA 20 0.0153
204 HYPERTRIGLYCERIDAEMIA 89 0.0152
205 PRE-ECLAMPSIA 72 0.0151
206 BLOOD TRIGLYCERIDES ABNORMAL 13 0.0148
207 CACHEXIA 76 0.0148
208 RED BLOOD CELL ABNORMALITY 14 0.0146
209 PREMATURE BABY 435 0.0144
210 NEPHROPATHY TOXIC 161 0.0143
211 PREMATURE LABOUR 81 0.0143
212 RENAL TUBULAR ACIDOSIS 31 0.0142
213 PREMATURE DELIVERY 220 0.0138
214 HEPATOMEGALY 133 0.0135
215 CHOLESTATIC LIVER INJURY 30 0.0135
216 ANOGENITAL WARTS 12 0.0135
217 BRAIN HERNIATION 40 0.0134
218 PSYCHOMOTOR SKILLS IMPAIRED 35 0.0133
219 FOETAL GROWTH RESTRICTION 80 0.0131
220 LIVE BIRTH 109 0.0130
221 DRUG EXPOSURE DURING PREGNANCY 437 0.0128
222 DRUG EXPOSURE VIA BREAST MILK 14 0.0128
223 FOETAL DEATH 66 0.0127
224 ANHEDONIA 332 0.0126
225 NEONATAL DISORDER 20 0.0126
226 ARNOLD-CHIARI MALFORMATION 12 0.0126
227 HEART TRANSPLANT REJECTION 13 0.0125
228 HEPATOTOXICITY 278 0.0125
229 MICROCEPHALY 16 0.0125
230 EXPOSURE DURING PREGNANCY 774 0.0124
231 LIPIDS INCREASED 25 0.0124
232 NEUROTOXICITY 217 0.0124
233 PREMATURE SEPARATION OF PLACENTA 19 0.0123
234 NORMAL NEWBORN 67 0.0123
235 CEREBELLAR SYNDROME 27 0.0123
236 PARADOXICAL DRUG REACTION 45 0.0122
237 DEPRESSIVE SYMPTOM 43 0.0122
238 ABORTION SPONTANEOUS 480 0.0120
239 POSTPARTUM HAEMORRHAGE 16 0.0119
240 ANAEMIA MACROCYTIC 25 0.0117
241 STEVENS-JOHNSON SYNDROME 256 0.0115
242 ECTOPIC PREGNANCY 35 0.0114
243 TALIPES 35 0.0113
244 MOUTH INJURY 17 0.0112
245 HEPATITIS TOXIC 29 0.0111
246 OSTEOPENIA 167 0.0110
247 DEPRESSION SUICIDAL 38 0.0110
248 DEVELOPMENTAL DELAY 99 0.0110
249 PREGNANCY ON CONTRACEPTIVE 16 0.0110
250 METABOLIC SYNDROME 18 0.0109
251 TEARFULNESS 47 0.0109
252 RETINAL VASCULITIS 13 0.0109
253 CONGENITAL ANOMALY 84 0.0108
254 HISTOPLASMOSIS DISSEMINATED 17 0.0107
255 HYPOPHOSPHATAEMIA 79 0.0107
256 DYSMORPHISM 25 0.0106
257 ATYPICAL MYCOBACTERIAL INFECTION 15 0.0106
258 CUSHINGOID 34 0.0106
259 OLIGOHYDRAMNIOS 35 0.0105
260 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 34 0.0105
261 PREGNANCY 209 0.0104
262 CALCULUS URINARY 16 0.0104
263 EXPOSURE VIA BREAST MILK 41 0.0103
264 MENINGITIS VIRAL 14 0.0102
265 INSULIN RESISTANCE 21 0.0101
266 LICHENOID KERATOSIS 23 0.0101
267 HEPATITIS C 120 0.0099
268 ULCERATIVE KERATITIS 27 0.0098
269 GENITAL HERPES 15 0.0098
270 GENITAL RASH 14 0.0098
271 TREATMENT FAILURE 806 0.0097
272 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 78 0.0094
273 ABORTION MISSED 12 0.0094
274 PNEUMONIA PNEUMOCOCCAL 14 0.0094
275 DEAFNESS BILATERAL 16 0.0094
276 OSTEOPOROTIC FRACTURE 18 0.0094
277 HYPERLIPIDAEMIA 112 0.0094
278 RENAL COLIC 21 0.0093
279 SECONDARY ADRENOCORTICAL INSUFFICIENCY 14 0.0093
280 NEONATAL RESPIRATORY DISTRESS SYNDROME 32 0.0090
281 APLASIA PURE RED CELL 31 0.0090
282 RENAL INFARCT 13 0.0090
283 HEPATITIS 229 0.0089
284 OSTEOPOROSIS 367 0.0089
285 AUTOIMMUNE HEPATITIS 62 0.0089
286 HYPERPARATHYROIDISM SECONDARY 22 0.0088
287 TREATMENT NONCOMPLIANCE 480 0.0088
288 CYTOLYTIC HEPATITIS 29 0.0087
289 CONJUNCTIVAL HYPERAEMIA 31 0.0087
290 ECONOMIC PROBLEM 130 0.0086
291 PREGNANCY WITH IMPLANT CONTRACEPTIVE 40 0.0085
292 HYDROCEPHALUS 46 0.0084
293 MATERNAL EXPOSURE DURING PREGNANCY 741 0.0083
294 HEPATIC NECROSIS 31 0.0082
295 PROTEINURIA 156 0.0082
296 ORAL CANDIDIASIS 107 0.0081
297 METABOLIC DISORDER 47 0.0081
298 LACTIC ACIDOSIS 258 0.0080
299 CONGESTIVE CARDIOMYOPATHY 33 0.0079
300 SPLENOMEGALY 91 0.0078
301 TOXIC EPIDERMAL NECROLYSIS 117 0.0077
302 DRUG INTERACTION 1218 0.0077
303 BLOOD PHOSPHORUS DECREASED 28 0.0077
304 VITRITIS 14 0.0076
305 DRUG-INDUCED LIVER INJURY 236 0.0075
306 GRANULOMA 26 0.0075
307 HEPATIC CYTOLYSIS 95 0.0074
308 JAUNDICE NEONATAL 14 0.0074
309 GASTROENTERITIS 107 0.0073
310 HEPATIC ENCEPHALOPATHY 67 0.0072
311 FIBROSIS 22 0.0071
312 HEPATITIS FULMINANT 21 0.0071
313 MENINGITIS 47 0.0070
314 CHOREA 12 0.0070
315 HYPERCHOLESTEROLAEMIA 67 0.0069
316 ATTENTION DEFICIT HYPERACTIVITY DISORDER 29 0.0069
317 ACUTE PSYCHOSIS 17 0.0069
318 BREAST DISORDER 14 0.0069
319 INTRACRANIAL PRESSURE INCREASED 38 0.0068
320 ENCEPHALITIS 47 0.0068
321 DRUG LEVEL INCREASED 112 0.0068
322 CYTOMEGALOVIRUS TEST POSITIVE 12 0.0067
323 BRONCHOPNEUMONIA 23 0.0067
324 DILATATION VENTRICULAR 14 0.0067
325 HEPATITIS CHOLESTATIC 40 0.0066
326 SKIN TOXICITY 37 0.0065
327 EXOPHTHALMOS 14 0.0065
328 DIPLOPIA 169 0.0065
329 HISTIOCYTOSIS HAEMATOPHAGIC 19 0.0064
330 ASPARTATE AMINOTRANSFERASE INCREASED 337 0.0063
331 HEPATIC STEATOSIS 118 0.0063
332 ATRIAL SEPTAL DEFECT 53 0.0063
333 ALANINE AMINOTRANSFERASE INCREASED 388 0.0063
334 ATAXIA 75 0.0063
335 HEPATIC CIRRHOSIS 118 0.0063
336 GAMMA-GLUTAMYLTRANSFERASE INCREASED 138 0.0062
337 CLEFT PALATE 12 0.0062
338 DERMATITIS EXFOLIATIVE 31 0.0062
339 FAILURE TO THRIVE 32 0.0062
340 STRABISMUS 18 0.0061
341 LIVER TRANSPLANT 22 0.0060
342 FOREIGN BODY 24 0.0060
343 RASH MACULO-PAPULAR 133 0.0060
344 MYOPATHY 50 0.0058
345 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 278 0.0058
346 HEPATOCELLULAR DAMAGE 13 0.0058
347 JAUNDICE 155 0.0058
348 PNEUMOCYSTIS JIROVECII PNEUMONIA 57 0.0057
349 POLYMYALGIA RHEUMATICA 18 0.0057
350 DERMATITIS ALLERGIC 71 0.0056
351 CEREBRAL ISCHAEMIA 29 0.0056
352 NERVOUS SYSTEM DISORDER 175 0.0056
353 CERVICAL DYSPLASIA 12 0.0055
354 CREATININE RENAL CLEARANCE DECREASED 22 0.0055
355 PEPTIC ULCER 18 0.0054
356 LYMPHADENOPATHY 192 0.0054
357 HEPATIC FAILURE 163 0.0054
358 NEPHROPATHY 50 0.0053
359 LIPASE INCREASED 41 0.0053
360 END STAGE RENAL DISEASE 97 0.0053
361 NEUROLOGICAL SYMPTOM 30 0.0052
362 HYPERBILIRUBINAEMIA 54 0.0052
363 BLOOD CREATININE ABNORMAL 18 0.0052
364 ACUTE HEPATIC FAILURE 71 0.0052
365 GROWTH RETARDATION 15 0.0051
366 PROTEIN URINE PRESENT 25 0.0050
367 MALNUTRITION 56 0.0050
368 BLOOD BILIRUBIN INCREASED 135 0.0050
369 BUNDLE BRANCH BLOCK LEFT 21 0.0049
370 RHINITIS ALLERGIC 22 0.0049
371 UMBILICAL HERNIA 23 0.0049
372 RENAL IMPAIRMENT 411 0.0049
373 HYPERREFLEXIA 17 0.0049
374 ODYNOPHAGIA 29 0.0049
375 GESTATIONAL DIABETES 23 0.0048
376 TRANSAMINASES INCREASED 106 0.0048
377 VITAMIN D DEFICIENCY 46 0.0047
378 CREPITATIONS 14 0.0047
379 RASH MORBILLIFORM 13 0.0047
380 HOMICIDAL IDEATION 19 0.0047
381 NEPHROTIC SYNDROME 32 0.0047
382 BONE DENSITY DECREASED 146 0.0047
383 BLOOD TRIGLYCERIDES INCREASED 82 0.0046
384 HEPATITIS ACUTE 30 0.0046
385 RENAL TUBULAR NECROSIS 45 0.0046
386 CHEST X-RAY ABNORMAL 14 0.0046
387 DRUG TOXICITY 62 0.0045
388 ANAEMIA 861 0.0045
389 LUNG CANCER METASTATIC 13 0.0045
390 AREFLEXIA 12 0.0045
391 NECROSIS 25 0.0045
392 TONGUE DISCOMFORT 19 0.0045
393 RENAL FAILURE ACUTE 189 0.0044
394 DRUG LEVEL DECREASED 45 0.0044
395 HEPATITIS B REACTIVATION 14 0.0044
396 GLOMERULAR FILTRATION RATE DECREASED 54 0.0044
397 DRUG LEVEL BELOW THERAPEUTIC 24 0.0043
398 HEPATOCELLULAR CARCINOMA 33 0.0043
399 CHOLESTASIS 83 0.0043
400 MIXED LIVER INJURY 13 0.0043
401 CHRONIC KIDNEY DISEASE 328 0.0043
402 ACUTE MYOCARDIAL INFARCTION 127 0.0043
403 BACTERIAL SEPSIS 14 0.0043
404 ENCEPHALOPATHY 105 0.0043
405 SUSPECTED COVID-19 14 0.0042
406 BLOOD CREATININE INCREASED 274 0.0042
407 DRUG LEVEL ABOVE THERAPEUTIC 19 0.0041
408 HYPERURICAEMIA 17 0.0041
409 EOSINOPHILIA 72 0.0041
410 BLOOD ALKALINE PHOSPHATASE INCREASED 102 0.0041
411 ANOREXIA 52 0.0040
412 LEFT VENTRICULAR DYSFUNCTION 27 0.0040
413 DERMATITIS EXFOLIATIVE GENERALISED 14 0.0040
414 MALABSORPTION 21 0.0040
415 ASCITES 118 0.0040
416 CEREBRAL ATROPHY 16 0.0040
417 PAPILLOEDEMA 18 0.0040
418 PSYCHOTIC DISORDER 117 0.0040
419 VITAMIN B12 DEFICIENCY 16 0.0039
420 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 13 0.0039
421 GLUCOSE TOLERANCE IMPAIRED 23 0.0039
422 NASAL POLYPS 19 0.0039
423 BK VIRUS INFECTION 13 0.0039
424 HERPES SIMPLEX 25 0.0038
425 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 98 0.0038
426 AUTOIMMUNE HAEMOLYTIC ANAEMIA 13 0.0038
427 LOW DENSITY LIPOPROTEIN INCREASED 29 0.0037
428 PANCYTOPENIA 208 0.0037
429 SKIN LESION 102 0.0037
430 PARANOIA 64 0.0037
431 OCULAR ICTERUS 16 0.0037
432 EPSTEIN-BARR VIRUS INFECTION 23 0.0037
433 PSYCHIATRIC SYMPTOM 27 0.0037
434 INTESTINAL ISCHAEMIA 20 0.0036
435 ORAL DISORDER 26 0.0035
436 POLYDIPSIA 14 0.0035
437 GINGIVITIS 19 0.0035
438 LEUKOENCEPHALOPATHY 13 0.0035
439 LYMPHOEDEMA 24 0.0035
440 BLOOD CREATINE PHOSPHOKINASE INCREASED 99 0.0034
441 MULTI-ORGAN FAILURE 59 0.0034
442 MULTIPLE FRACTURES 56 0.0034
443 BLOOD ALBUMIN DECREASED 27 0.0034
444 ADRENAL INSUFFICIENCY 41 0.0034
445 CYTOMEGALOVIRUS VIRAEMIA 15 0.0034
446 OSTEONECROSIS 110 0.0033
447 HYDRONEPHROSIS 25 0.0033
448 PROCEDURAL HAEMORRHAGE 13 0.0033
449 GENERALISED TONIC-CLONIC SEIZURE 55 0.0033
450 LUNG NEOPLASM 14 0.0033
451 SKIN NECROSIS 17 0.0033
452 PNEUMONIA BACTERIAL 30 0.0033
453 TACHYPNOEA 44 0.0032
454 PYELONEPHRITIS 28 0.0032
455 RENAL FUNCTION TEST ABNORMAL 15 0.0032
456 ABDOMINAL TENDERNESS 16 0.0032
457 PRESCRIBED OVERDOSE 62 0.0032
458 LIVER FUNCTION TEST ABNORMAL 93 0.0032
459 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 28 0.0032
460 PATHOLOGICAL FRACTURE 16 0.0031
461 DECREASED ACTIVITY 34 0.0031
462 GRAND MAL CONVULSION 29 0.0031
463 SKIN ATROPHY 18 0.0031
464 TRANSPLANT REJECTION 25 0.0031
465 PANCREATITIS ACUTE 70 0.0031
466 EMOTIONAL DISTRESS 376 0.0031
467 HEPATOCELLULAR INJURY 44 0.0031
468 TOXIC SKIN ERUPTION 31 0.0031
469 HEMIPARESIS 52 0.0031
470 RESPIRATORY DISTRESS 84 0.0030
471 RENAL FAILURE 404 0.0030
472 METABOLIC ACIDOSIS 97 0.0030
473 TYPE 1 DIABETES MELLITUS 18 0.0030
474 QUALITY OF LIFE DECREASED 40 0.0030
475 PRODUCT SIZE ISSUE 16 0.0030
476 ABNORMAL DREAMS 82 0.0030
477 BEHAVIOUR DISORDER 16 0.0030
478 TUMOUR LYSIS SYNDROME 26 0.0030
479 LUNG INFILTRATION 26 0.0029
480 LIVER DISORDER 130 0.0029
481 SUDDEN DEATH 31 0.0029
482 DEPRESSION 666 0.0029
483 PERIPHERAL SENSORY NEUROPATHY 17 0.0029
484 BONE MARROW FAILURE 59 0.0029
485 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 49 0.0029
486 HAEMODIALYSIS 24 0.0029
487 BLOOD IRON DECREASED 33 0.0028
488 ACUTE CORONARY SYNDROME 23 0.0028
489 CARDIAC MURMUR 24 0.0028
490 KLEBSIELLA INFECTION 14 0.0028
491 VISUAL FIELD DEFECT 20 0.0028
492 ACIDOSIS 21 0.0027
493 CHOLANGITIS 17 0.0027
494 CLOSTRIDIUM DIFFICILE COLITIS 29 0.0027
495 UVEITIS 37 0.0027
496 PANCREATITIS 144 0.0027
497 CORONAVIRUS INFECTION 18 0.0027
498 ARTERIOSCLEROSIS CORONARY ARTERY 18 0.0027
499 HYPOVOLAEMIC SHOCK 13 0.0027
500 BENIGN PROSTATIC HYPERPLASIA 14 0.0027
501 DRUG ERUPTION 48 0.0027
502 HEPATIC FUNCTION ABNORMAL 101 0.0027
503 LYMPHOPENIA 38 0.0027
504 POLYURIA 22 0.0027
505 NEUROPATHY PERIPHERAL 255 0.0027
506 APLASTIC ANAEMIA 14 0.0027
507 HAEMOLYTIC ANAEMIA 24 0.0027
508 ENDOPHTHALMITIS 16 0.0027
509 PANCREATIC DISORDER 13 0.0026
510 PALLOR 71 0.0026
511 HERPES VIRUS INFECTION 15 0.0026
512 BLOOD CHOLESTEROL ABNORMAL 12 0.0026
513 PAPULE 18 0.0026
514 COLITIS MICROSCOPIC 12 0.0025
515 RENAL CYST 20 0.0025
516 MACULAR OEDEMA 14 0.0025
517 IMMUNOSUPPRESSION 22 0.0025
518 LIVER INJURY 61 0.0025
519 ACUTE KIDNEY INJURY 378 0.0025
520 LYMPHOMA 38 0.0025
521 GYNAECOMASTIA 76 0.0025
522 LEUKOPENIA 122 0.0024
523 BLOOD URIC ACID INCREASED 14 0.0024
524 SPINAL COMPRESSION FRACTURE 20 0.0024
525 OLIGURIA 15 0.0024
526 HEMIPLEGIA 20 0.0024
527 HYPOTONIA 24 0.0024
528 DIABETES MELLITUS 182 0.0024
529 CORONARY ARTERY STENOSIS 12 0.0024
530 NIGHTMARE 81 0.0023
531 POLYNEUROPATHY 28 0.0023
532 BLOOD LACTATE DEHYDROGENASE INCREASED 37 0.0023
533 PYREXIA 806 0.0023
534 EYELID OEDEMA 27 0.0023
535 FOOT FRACTURE 44 0.0023
536 GASTRITIS 61 0.0023
537 HYPOALBUMINAEMIA 18 0.0023
538 TUBULOINTERSTITIAL NEPHRITIS 43 0.0023
539 BLOOD SODIUM DECREASED 43 0.0023
540 CARDIOMEGALY 28 0.0023
541 CARDIAC FAILURE ACUTE 15 0.0022
542 RALES 13 0.0022
543 HELICOBACTER INFECTION 23 0.0022
544 CHEILITIS 12 0.0022
545 SKIN HYPERPIGMENTATION 19 0.0022
546 BONE LOSS 33 0.0022
547 TORSADE DE POINTES 17 0.0022
548 PULMONARY HYPERTENSION 45 0.0022
549 ANGINA UNSTABLE 14 0.0022
550 BRAIN OEDEMA 27 0.0021
551 SEPSIS 236 0.0021
552 UNINTENDED PREGNANCY 22 0.0021
553 METASTASES TO LYMPH NODES 14 0.0021
554 NEPHROLITHIASIS 95 0.0021
555 PARKINSONISM 20 0.0020
556 DYSARTHRIA 77 0.0020
557 CENTRAL NERVOUS SYSTEM LESION 28 0.0020
558 ERECTILE DYSFUNCTION 52 0.0020
559 BACTERAEMIA 24 0.0020
560 ARTERIOSCLEROSIS 19 0.0020
561 FACE OEDEMA 34 0.0020
562 MENTAL DISORDER 87 0.0020
563 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 15 0.0020
564 HYPOKALAEMIA 92 0.0020
565 RHINITIS 16 0.0020
566 MYASTHENIA GRAVIS 16 0.0020
567 SHOCK HAEMORRHAGIC 16 0.0020
568 NEUTROPENIA 265 0.0019
569 SKIN MASS 13 0.0019
570 MITRAL VALVE INCOMPETENCE 22 0.0019
571 ABSCESS 31 0.0019
572 TOOTH LOSS 40 0.0019
573 CYTOMEGALOVIRUS INFECTION 32 0.0019
574 ACUTE RESPIRATORY DISTRESS SYNDROME 34 0.0019
575 MAJOR DEPRESSION 14 0.0019
576 RESPIRATORY RATE INCREASED 17 0.0019
577 SINUS TACHYCARDIA 27 0.0019
578 SKIN PLAQUE 16 0.0019
579 HEPATIC ENZYME INCREASED 129 0.0019
580 RHABDOMYOLYSIS 78 0.0019
581 PHARYNGITIS 23 0.0019
582 MYOCARDITIS 21 0.0018
583 AGRANULOCYTOSIS 34 0.0018
584 ULCER 29 0.0018
585 ERYTHEMA MULTIFORME 17 0.0018
586 HAEMOLYSIS 14 0.0018
587 MASS 25 0.0018
588 CONJUNCTIVITIS 33 0.0018
589 GASTROINTESTINAL DISORDER 159 0.0018
590 HYPERKALAEMIA 62 0.0018
591 DISEASE RECURRENCE 84 0.0018
592 DELIRIUM 61 0.0018
593 MOUTH ULCERATION 37 0.0018
594 IMMUNE SYSTEM DISORDER 23 0.0017
595 SKIN ULCER 45 0.0017
596 RASH GENERALISED 45 0.0017
597 HAEMATURIA 59 0.0017
598 COORDINATION ABNORMAL 24 0.0017
599 VISUAL ACUITY REDUCED 57 0.0017
600 ASPHYXIA 14 0.0017
601 CARDIOMYOPATHY 25 0.0017
602 HYPOTHYROIDISM 54 0.0017
603 ANXIETY 481 0.0017
604 PSYCHOMOTOR HYPERACTIVITY 28 0.0017
605 DYSPHAGIA 160 0.0017
606 RENAL INJURY 50 0.0017
607 BRONCHOPULMONARY ASPERGILLOSIS 13 0.0017
608 THROMBOCYTOPENIA 187 0.0017
609 MYOSITIS 15 0.0017
610 RIB FRACTURE 34 0.0017
611 CHOKING 32 0.0016
612 ELECTROLYTE IMBALANCE 19 0.0016
613 WEIGHT FLUCTUATION 17 0.0016
614 BLOOD DISORDER 13 0.0016
615 CEREBRAL DISORDER 12 0.0016
616 NIGHT SWEATS 52 0.0016
617 RENAL DISORDER 75 0.0016
618 RASH PAPULAR 36 0.0016
619 INTENTIONAL PRODUCT USE ISSUE 140 0.0016
620 BLOOD CHOLESTEROL INCREASED 74 0.0016
621 ESCHERICHIA INFECTION 13 0.0016
622 HAEMATOTOXICITY 15 0.0016
623 TYPE 2 DIABETES MELLITUS 53 0.0016
624 PERICARDIAL EFFUSION 36 0.0016
625 PHOTOPHOBIA 29 0.0015
626 HYPERCALCAEMIA 19 0.0015
627 GENERALISED OEDEMA 19 0.0015
628 HAEMOGLOBIN DECREASED 156 0.0015
629 SEPTIC SHOCK 66 0.0015
630 HYPOKINESIA 22 0.0015
631 PHOTOSENSITIVITY REACTION 25 0.0015
632 POISONING 19 0.0015
633 REBOUND EFFECT 17 0.0015
634 WRIST FRACTURE 18 0.0015
635 SLEEP DISORDER 105 0.0015
636 CONVULSION 84 0.0015
637 RESPIRATORY FAILURE 106 0.0015
638 CORONARY ARTERY DISEASE 44 0.0015
639 SKELETAL INJURY 15 0.0014
640 HYPOXIA 51 0.0014
641 HALLUCINATION, AUDITORY 23 0.0014
642 VENTRICULAR EXTRASYSTOLES 15 0.0014
643 TOXICITY TO VARIOUS AGENTS 243 0.0014
644 APATHY 21 0.0014
645 CHROMATURIA 32 0.0014
646 SUICIDAL IDEATION 129 0.0014
647 MYOCARDIAL ISCHAEMIA 16 0.0014
648 INTERNATIONAL NORMALISED RATIO INCREASED 40 0.0014
649 AGITATION 103 0.0014
650 HYPERTENSION 296 0.0014
651 ANGINA PECTORIS 40 0.0014
652 MUSCULOSKELETAL DISCOMFORT 24 0.0014
653 NO THERAPEUTIC RESPONSE 17 0.0014
654 SPEECH DISORDER 73 0.0014
655 APPENDICITIS 13 0.0014
656 ELECTROCARDIOGRAM QT PROLONGED 50 0.0014
657 HYPERTHYROIDISM 20 0.0014
658 SQUAMOUS CELL CARCINOMA 13 0.0014
659 BIPOLAR DISORDER 15 0.0014
660 BONE DISORDER 25 0.0014
661 AFFECT LABILITY 13 0.0013
662 HYPONATRAEMIA 76 0.0013
663 SHOCK 31 0.0013
664 MUSCLE ATROPHY 17 0.0013
665 HAEMATEMESIS 34 0.0013
666 MYALGIA 222 0.0013
667 GENERAL PHYSICAL HEALTH DETERIORATION 150 0.0013
668 CARPAL TUNNEL SYNDROME 18 0.0013
669 VAGINAL DISCHARGE 13 0.0013
670 CONFUSIONAL STATE 207 0.0013
671 IMMUNODEFICIENCY 19 0.0013
672 RASH 555 0.0013
673 VENTRICULAR TACHYCARDIA 21 0.0013
674 COAGULOPATHY 21 0.0013
675 PRURITUS GENERALISED 27 0.0012
676 DEATH 1073 0.0012
677 DRUG DISPENSING ERROR 19 0.0012
678 VOMITING 580 0.0012
679 CEREBRAL INFARCTION 30 0.0012
680 ANKLE FRACTURE 19 0.0012
681 RENAL PAIN 13 0.0012
682 DELUSION 19 0.0012
683 ABDOMINAL PAIN 282 0.0012
684 PNEUMOTHORAX 19 0.0012
685 BACTERIAL INFECTION 22 0.0012
686 MYELODYSPLASTIC SYNDROME 17 0.0012
687 CIRCULATORY COLLAPSE 20 0.0012
688 PULMONARY ARTERIAL HYPERTENSION 17 0.0012
689 DEEP VEIN THROMBOSIS 76 0.0012
690 CORONARY ARTERY OCCLUSION 16 0.0012
691 MYOCARDIAL INFARCTION 203 0.0012
692 GASTRIC ULCER 22 0.0012
693 ALTERED STATE OF CONSCIOUSNESS 25 0.0012
694 PLATELET COUNT INCREASED 15 0.0011
695 WEIGHT DECREASED 321 0.0011
696 NODULE 15 0.0011
697 DRUG INTOLERANCE 111 0.0011
698 DISSEMINATED INTRAVASCULAR COAGULATION 16 0.0011
699 BLOOD UREA INCREASED 19 0.0011
700 DEHYDRATION 151 0.0011
701 STAPHYLOCOCCAL INFECTION 37 0.0011
702 DISORIENTATION 44 0.0011
703 FRACTURE 21 0.0011
704 SYNOVITIS 20 0.0011
705 BLOOD POTASSIUM INCREASED 18 0.0011
706 JOINT STIFFNESS 29 0.0011
707 LUNG DISORDER 54 0.0011
708 HYPERGLYCAEMIA 40 0.0011
709 PULMONARY EMBOLISM 104 0.0011
710 CHOLECYSTITIS 13 0.0011
711 PRODUCT PHYSICAL ISSUE 22 0.0011
712 OEDEMA 59 0.0011
713 RASH ERYTHEMATOUS 52 0.0011
714 CYANOSIS 17 0.0011
715 IRRITABILITY 65 0.0011
716 BLINDNESS 44 0.0011
717 DEPRESSED MOOD 57 0.0011
718 LOWER RESPIRATORY TRACT INFECTION 49 0.0011
719 MIDDLE INSOMNIA 20 0.0011
720 TACHYCARDIA 95 0.0011
721 BLOOD CALCIUM DECREASED 12 0.0011
722 OBESITY 17 0.0011
723 CANDIDA INFECTION 18 0.0011
724 SKIN REACTION 15 0.0011
725 HERPES ZOSTER 61 0.0011
726 CEREBRAL HAEMORRHAGE 38 0.0011
727 LETHARGY 60 0.0010
728 HAEMOPTYSIS 29 0.0010
729 DISTURBANCE IN ATTENTION 56 0.0010
730 ASTHENIA 389 0.0010
731 TINNITUS 47 0.0010
732 COMA 48 0.0010
733 ORAL DISCOMFORT 14 0.0010
734 HIATUS HERNIA 13 0.0010
735 RASH MACULAR 35 0.0010
736 RESTLESSNESS 36 0.0010
737 RASH PRURITIC 53 0.0010
738 CHOLELITHIASIS 32 0.0010
739 HYPERSENSITIVITY 180 0.0010
740 AMENORRHOEA 17 0.0010
741 VERTIGO 59 0.0010
742 ACUTE MYELOID LEUKAEMIA 15 0.0010
743 INTERVERTEBRAL DISC PROTRUSION 21 0.0010
744 APHASIA 29 0.0010
745 CARDIAC FAILURE 77 0.0010
746 ABNORMAL BEHAVIOUR 38 0.0010
747 UPPER GASTROINTESTINAL HAEMORRHAGE 16 0.0010
748 DYSURIA 35 0.0009
749 PNEUMONIA 307 0.0009
750 HALLUCINATION, VISUAL 20 0.0009
751 CONDITION AGGRAVATED 288 0.0009
752 EYE DISORDER 31 0.0009
753 HYPOPHAGIA 24 0.0009
754 GLAUCOMA 18 0.0009
755 THERAPY NON-RESPONDER 42 0.0009
756 MOBILITY DECREASED 67 0.0009
757 LIVER FUNCTION TEST INCREASED 20 0.0009
758 SKIN DISORDER 31 0.0009
759 DIARRHOEA 595 0.0009
760 BLINDNESS UNILATERAL 13 0.0009
761 ABDOMINAL DISTENSION 95 0.0009
762 DEPRESSED LEVEL OF CONSCIOUSNESS 36 0.0009
763 MUSCULAR WEAKNESS 103 0.0009
764 ANGIOEDEMA 40 0.0009
765 HEAD DISCOMFORT 16 0.0009
766 HALLUCINATION 68 0.0009
767 ADVERSE EVENT 83 0.0009
768 AGGRESSION 45 0.0009
769 DYSSTASIA 26 0.0009
770 OEDEMA PERIPHERAL 108 0.0009
771 LEUKOCYTOSIS 16 0.0009
772 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 46 0.0009
773 DRUG WITHDRAWAL SYNDROME NEONATAL 13 0.0009
774 URINARY INCONTINENCE 26 0.0009
775 GASTRIC DISORDER 30 0.0009
776 SENSORY DISTURBANCE 14 0.0009
777 BLOOD POTASSIUM DECREASED 26 0.0009
778 COGNITIVE DISORDER 40 0.0009
779 MANIA 14 0.0009
780 HIP ARTHROPLASTY 13 0.0008
781 INSOMNIA 226 0.0008
782 LABORATORY TEST ABNORMAL 25 0.0008
783 IMPAIRED WORK ABILITY 18 0.0008
784 DIABETIC KETOACIDOSIS 20 0.0008
785 PAIN 511 0.0008
786 MENTAL STATUS CHANGES 23 0.0008
787 GAIT DISTURBANCE 157 0.0008
788 ABASIA 20 0.0008
789 SUICIDE ATTEMPT 49 0.0008
790 COUGH 226 0.0008
791 RED BLOOD CELL COUNT DECREASED 23 0.0008
792 DEAFNESS 21 0.0008
793 ARRHYTHMIA 38 0.0008
794 PNEUMONIA ASPIRATION 20 0.0008
795 PRODUCTIVE COUGH 38 0.0008
796 BLOOD URINE PRESENT 15 0.0008
797 PLEURAL EFFUSION 48 0.0008
798 FEBRILE NEUTROPENIA 52 0.0008
799 THIRST 14 0.0008
800 PERITONITIS 16 0.0008
801 DYSPNOEA EXERTIONAL 29 0.0008
802 WEIGHT INCREASED 172 0.0008
803 DERMATITIS 16 0.0008
804 HAEMATOCRIT DECREASED 15 0.0008
805 DECREASED APPETITE 175 0.0008
806 MOVEMENT DISORDER 24 0.0007
807 CHEST PAIN 138 0.0007
808 POLLAKIURIA 31 0.0007
809 POOR QUALITY SLEEP 16 0.0007
810 NAUSEA 588 0.0007
811 PLATELET COUNT DECREASED 79 0.0007
812 SWELLING FACE 48 0.0007
813 RESPIRATORY DISORDER 22 0.0007
814 BODY TEMPERATURE INCREASED 15 0.0007
815 DIABETES MELLITUS INADEQUATE CONTROL 13 0.0007
816 LOWER LIMB FRACTURE 14 0.0007
817 AMNESIA 47 0.0007
818 HYPOGLYCAEMIA 35 0.0007
819 THROMBOSIS 58 0.0007
820 EPILEPSY 22 0.0007
821 OSTEOMYELITIS 13 0.0007
822 CARDIO-RESPIRATORY ARREST 30 0.0007
823 SOMNOLENCE 142 0.0007
824 EATING DISORDER 15 0.0007
825 CARDIAC ARREST 58 0.0007
826 HYPOAESTHESIA 105 0.0007
827 SPINAL FRACTURE 14 0.0007
828 CARDIAC FAILURE CONGESTIVE 56 0.0007
829 DRUG ABUSE 58 0.0007
830 SEIZURE 80 0.0007
831 PALPITATIONS 81 0.0007
832 SKIN EXFOLIATION 58 0.0007
833 INTERSTITIAL LUNG DISEASE 33 0.0007
834 FEMUR FRACTURE 21 0.0007
835 CARDIOVASCULAR DISORDER 17 0.0007
836 INTESTINAL OBSTRUCTION 25 0.0007
837 WRONG TECHNIQUE IN DRUG USAGE PROCESS 24 0.0007
838 C-REACTIVE PROTEIN INCREASED 24 0.0007
839 INFLAMMATION 34 0.0007
840 UPPER LIMB FRACTURE 13 0.0007
841 CHILLS 76 0.0006
842 HYPOTENSION 130 0.0006
843 WHITE BLOOD CELL COUNT DECREASED 69 0.0006
844 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18 0.0006
845 DRUG INEFFECTIVE 834 0.0006
846 URINARY RETENTION 21 0.0006
847 DRY MOUTH 51 0.0006
848 MALAISE 275 0.0006
849 THERAPEUTIC RESPONSE DECREASED 38 0.0006
850 NECK PAIN 35 0.0006
851 WHITE BLOOD CELL COUNT INCREASED 24 0.0006
852 PRODUCT SUBSTITUTION ISSUE 36 0.0006
853 COMPLETED SUICIDE 52 0.0006
854 CELLULITIS 31 0.0006
855 PARAESTHESIA 96 0.0006
856 DYSPNOEA 335 0.0006
857 MUSCULOSKELETAL PAIN 31 0.0006
858 DRUG ADMINISTRATION ERROR 18 0.0006
859 MYELOSUPPRESSION 21 0.0006
860 DIZZINESS 290 0.0006
861 RESPIRATORY TRACT INFECTION 15 0.0006
862 NO ADVERSE EVENT 103 0.0006
863 OSTEOARTHRITIS 24 0.0006
864 NEUTROPHIL COUNT DECREASED 23 0.0006
865 DRUG EFFECT DECREASED 30 0.0006
866 HEADACHE 348 0.0006
867 ERYTHEMA 114 0.0006
868 INFECTION 80 0.0006
869 GASTROINTESTINAL HAEMORRHAGE 46 0.0005
870 ACCIDENTAL OVERDOSE 20 0.0005
871 PRODUCT USE IN UNAPPROVED INDICATION 135 0.0005
872 HYPERHIDROSIS 70 0.0005
873 URINARY TRACT INFECTION 92 0.0005
874 BLISTER 30 0.0005
875 OROPHARYNGEAL PAIN 49 0.0005
876 FLATULENCE 30 0.0005
877 ILL-DEFINED DISORDER 32 0.0005
878 FATIGUE 409 0.0005
879 VISION BLURRED 72 0.0005
880 PANIC ATTACK 19 0.0005
881 EMOTIONAL DISORDER 16 0.0005
882 HAEMORRHAGE 54 0.0005
883 GLYCOSYLATED HAEMOGLOBIN INCREASED 13 0.0005
884 ABDOMINAL PAIN LOWER 13 0.0005
885 PULMONARY OEDEMA 23 0.0005
886 BONE PAIN 30 0.0005
887 DEMENTIA 14 0.0005
888 BLOOD PRESSURE DECREASED 33 0.0005
889 ARTHRALGIA 206 0.0005
890 OVERDOSE 106 0.0005
891 CEREBROVASCULAR ACCIDENT 83 0.0005
892 OFF LABEL USE 426 0.0005
893 FEAR 13 0.0005
894 HOSPITALISATION 74 0.0005
895 LOSS OF CONSCIOUSNESS 60 0.0005
896 ADVERSE DRUG REACTION 42 0.0005
897 PRURITUS 178 0.0005
898 DRY EYE 23 0.0005
899 GASTROOESOPHAGEAL REFLUX DISEASE 37 0.0005
900 BRADYCARDIA 24 0.0005
901 FLUID RETENTION 23 0.0005
902 LIP SWELLING 15 0.0004
903 EYE PAIN 25 0.0004
904 NERVOUSNESS 23 0.0004
905 CHEST DISCOMFORT 45 0.0004
906 LUNG NEOPLASM MALIGNANT 18 0.0004
907 CATARACT 26 0.0004
908 SKIN DISCOLOURATION 20 0.0004
909 UPPER RESPIRATORY TRACT INFECTION 20 0.0004
910 NEOPLASM PROGRESSION 15 0.0004
911 STOMATITIS 26 0.0004
912 TREMOR 71 0.0004
913 DYSPHONIA 25 0.0004
914 DYSPEPSIA 42 0.0004
915 PRODUCT USE ISSUE 80 0.0004
916 DYSKINESIA 17 0.0004
917 BACK PAIN 97 0.0004
918 PAIN IN EXTREMITY 123 0.0004
919 COVID-19 71 0.0004
920 HIP FRACTURE 13 0.0004
921 ABDOMINAL PAIN UPPER 83 0.0004
922 ECZEMA 21 0.0004
923 MEDICATION ERROR 22 0.0004
924 RECTAL HAEMORRHAGE 17 0.0004
925 SYSTEMIC LUPUS ERYTHEMATOSUS 14 0.0004
926 VAGINAL HAEMORRHAGE 17 0.0004
927 OXYGEN SATURATION DECREASED 22 0.0004
928 VIRAL INFECTION 13 0.0004
929 SYNCOPE 39 0.0004
930 DISEASE PROGRESSION 46 0.0004
931 PROSTATE CANCER 31 0.0004
932 CARDIAC DISORDER 36 0.0004
933 ANGER 13 0.0004
934 URTICARIA 63 0.0004
935 FALL 121 0.0004
936 OCULAR HYPERAEMIA 17 0.0004
937 UNEVALUABLE EVENT 27 0.0004
938 THERAPY CESSATION 18 0.0004
939 ALOPECIA 68 0.0003
940 DISCOMFORT 21 0.0003
941 HEART RATE INCREASED 34 0.0003
942 COLITIS 13 0.0003
943 EPISTAXIS 25 0.0003
944 NEOPLASM MALIGNANT 22 0.0003
945 ASTHMA 37 0.0003
946 HAEMATOCHEZIA 18 0.0003
947 DYSGEUSIA 24 0.0003
948 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
949 INFLUENZA LIKE ILLNESS 25 0.0003
950 VISUAL IMPAIRMENT 37 0.0003
951 DRUG WITHDRAWAL SYNDROME 26 0.0003
952 RHINORRHOEA 19 0.0003
953 ARTHRITIS 23 0.0003
954 SWELLING 27 0.0003
955 INJURY 20 0.0003
956 MEMORY IMPAIRMENT 39 0.0003
957 BLOOD GLUCOSE INCREASED 53 0.0003
958 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 20 0.0003
959 CONSTIPATION 61 0.0003
960 DRUG DOSE OMISSION 45 0.0003
961 ABDOMINAL DISCOMFORT 45 0.0003
962 MUSCLE SPASMS 49 0.0003
963 PRODUCT DOSE OMISSION 17 0.0003
964 ATRIAL FIBRILLATION 25 0.0003
965 MUSCULOSKELETAL STIFFNESS 22 0.0003
966 BRONCHITIS 18 0.0002
967 BURNING SENSATION 17 0.0002
968 BLOOD PRESSURE INCREASED 36 0.0002
969 INTENTIONAL OVERDOSE 15 0.0002
970 FEELING ABNORMAL 56 0.0002
971 BALANCE DISORDER 20 0.0002
972 FEELING HOT 14 0.0002
973 PRODUCT DOSE OMISSION ISSUE 64 0.0002
974 INTENTIONAL PRODUCT MISUSE 19 0.0002
975 FLUSHING 22 0.0002
976 ACNE 15 0.0002
977 INCORRECT DOSE ADMINISTERED 41 0.0002
978 CONTUSION 17 0.0002
979 INFLUENZA 19 0.0002
980 PERIPHERAL SWELLING 26 0.0002
981 PRODUCT QUALITY ISSUE 22 0.0002
982 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 31 0.0002
983 NASOPHARYNGITIS 27 0.0001
984 JOINT SWELLING 15 0.0001
985 RHEUMATOID ARTHRITIS 14 0.0001
986 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 21 0.0001
987 DRY SKIN 14 0.0001
988 PSORIASIS 13 0.0001
989 INJECTION SITE PAIN 14 0.0000